Fertility Practices Meet Ethics Around the World

FINE LINESThom Graves MediaThe ethical dimension of assisted reproduction cannot be divorced from the science, as was illustrated by two seemingly contradictory decisions by the United Kingdom's Human Fertilization and Embryology Authority. The HFEA approved an application for use of preimplantation genetic diagnosis (PGD) for a couple that had an existing child with Fanconi anemia. They wished to conceive a second child, both free of the disease and HLA compatible with the first. Stem cells tak

Written byBrendan Maher
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Thom Graves Media

The ethical dimension of assisted reproduction cannot be divorced from the science, as was illustrated by two seemingly contradictory decisions by the United Kingdom's Human Fertilization and Embryology Authority. The HFEA approved an application for use of preimplantation genetic diagnosis (PGD) for a couple that had an existing child with Fanconi anemia. They wished to conceive a second child, both free of the disease and HLA compatible with the first. Stem cells taken from umbilical cord blood could be used to treat the elder sibling.

Yet the HFEA rejected a similar application from a couple with a child who has diamond blackfan anemia. DBA presumably involves a sporadic mutation rather than a hereditary condition, and therefore, argued the HFEA, PGD could not ensure freedom from disease. In vitro fertilization pioneer Robert Edwards argues that under this reasoning, parents with such ill children might as well be banned ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies